Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/83603
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCar, Josipen
dc.contributor.authorTan, Woan Shinen
dc.contributor.authorHuang, Zhilianen
dc.contributor.authorSloot, Peteren
dc.contributor.authorFranklin, Bryony Deanen
dc.date.accessioned2017-06-14T06:56:22Zen
dc.date.accessioned2019-12-06T15:26:33Z-
dc.date.available2017-06-14T06:56:22Zen
dc.date.available2019-12-06T15:26:33Z-
dc.date.issued2017en
dc.identifier.citationCar, J., Tan, W. S., Huang, Z., Sloot, P., & Franklin, B. D. (2017). eHealth in the future of medications management: personalisation, monitoring and adherence. BMC Medicine, 15, 73-.en
dc.identifier.issn1741-7015en
dc.identifier.urihttps://hdl.handle.net/10356/83603-
dc.description.abstractBACKGROUND: Globally, healthcare systems face major challenges with medicines management and medication adherence. Medication adherence determines medication effectiveness and can be the single most effective intervention for improving health outcomes. In anticipation of growth in eHealth interventions worldwide, we explore the role of eHealth in the patients' medicines management journey in primary care, focusing on personalisation and intelligent monitoring for greater adherence. DISCUSSION: eHealth offers opportunities to transform every step of the patient's medicines management journey. From booking appointments, consultation with a healthcare professional, decision-making, medication dispensing, carer support, information acquisition and monitoring, to learning about medicines and their management in daily life. It has the potential to support personalisation and monitoring and thus lead to better adherence. For some of these dimensions, such as supporting decision-making and providing reminders and prompts, evidence is stronger, but for many others more rigorous research is urgently needed. CONCLUSIONS: Given the potential benefits and barriers to eHealth in medicines management, a fine balance needs to be established between evidence-based integration of technologies and constructive experimentation that could lead to a game-changing breakthrough. A concerted, transdisciplinary approach adapted to different contexts, including low- and middle-income contries is required to realise the benefits of eHealth at scale.en
dc.format.extent9 p.en
dc.language.isoenen
dc.relation.ispartofseriesBMC Medicineen
dc.rights© 2017 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en
dc.subjectAppsen
dc.subjectDrug monitoringen
dc.titleeHealth in the future of medications management: personalisation, monitoring and adherenceen
dc.typeJournal Articleen
dc.contributor.schoolInterdisciplinary Graduate School (IGS)en
dc.contributor.schoolLee Kong Chian School of Medicine (LKCMedicine)en
dc.contributor.organizationComplexity Instituteen
dc.identifier.doi10.1186/s12916-017-0838-0en
dc.description.versionPublished versionen
item.fulltextWith Fulltext-
item.grantfulltextopen-
Appears in Collections:IGS Journal Articles
LKCMedicine Journal Articles

SCOPUSTM   
Citations

26
Updated on Sep 1, 2020

PublonsTM
Citations

28
Updated on Feb 23, 2021

Page view(s) 50

321
Updated on Feb 28, 2021

Download(s) 50

66
Updated on Feb 28, 2021

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.